Molecule Details
| InChIKey | DVZZYZNFLHFCPI-SCFUHWHPSA-N |
|---|---|
| Compound Name | 2-[2-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]ethyl]-1-(2-bromophenyl)guanidine |
| Canonical SMILES | N=C(NCCSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)Nc1ccccc1Br |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 7 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.37 |
| Source | ChEMBL |
2D Structure
Activity Profile
Target Activities (7)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| Q86X55 | CARM1 | Homo sapiens | Human | PF11531 PF06325 PF22528 | 8.3 | IC50 | ChEMBL |
| Q99873 | PRMT1 | Homo sapiens | Human | PF13649 PF22528 | 7.8 | IC50 | ChEMBL |
| O14744 | PRMT5 | Homo sapiens | Human | PF05185 PF17286 PF17285 | 7.7 | IC50 | ChEMBL |
| Q96LA8 | PRMT6 | Homo sapiens | Human | PF13649 PF22528 | 7.5 | IC50 | ChEMBL |
| Q9NR22 | PRMT8 | Homo sapiens | Human | PF06325 PF22528 | 7.5 | IC50 | ChEMBL |
| O60678 | PRMT3 | Homo sapiens | Human | PF21137 PF21336 PF06325 PF22528 | 6.5 | IC50 | ChEMBL |
| Q9NVM4 | PRMT7 | Homo sapiens | Human | PF06325 PF22528 | 6.3 | IC50 | ChEMBL |